Chapter 22: Hypothalamic integration of immune function and metabolism

Progress in Brain Research

Volumn 153, Issue , 2006, Pages 367-405

  Guijarro, Ana ^a   Laviano, Alessandro ^b   Meguid, Michael M ^a  

^a University Hospital   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CHOLECYSTOKININ; CORTICOSTERONE; CYTOKINE; DOCOSAHEXAENOIC ACID; DOPAMINE; FISH OIL; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MIANSERIN; NEUROPEPTIDE Y; NICOTINE; OMEGA 3 FATTY ACID; SEROTONIN; SEROTONIN ANTAGONIST; SEX HORMONE; SULPIRIDE; TRIACYLGLYCEROL; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG; XYLOSE; PEPTIDE HORMONE;

ACUTE PHASE RESPONSE; ADIPOSE TISSUE; ANOREXIA; ANTERIOR HYPOTHALAMUS; ANTIINFLAMMATORY ACTIVITY; ARCUATE NUCLEUS; BRAIN METABOLISM; BRAIN NERVE CELL; CACHEXIA; CANCER; CANCER INHIBITION; CANCER SURGERY; CARBOHYDRATE ABSORPTION; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DIET THERAPY; DOPAMINE BRAIN LEVEL; DOPAMINE METABOLISM; DYSLIPIDEMIA; FEEDING; FOOD INTAKE; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS; HYPOTHALAMUS FUNCTION; HYPOTHALAMUS NUCLEUS; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFECTION; INFLAMMATION; INJURY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAVENOUS FEEDING; LIPID STORAGE; MEAL; MEDIATOR RELEASE; MESENTERY; METABOLIC DISORDER; METABOLIC REGULATION; METABOLIC SYNDROME X; METABOLISM; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONHUMAN; NUTRIENT AVAILABILITY; OBESITY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSORY SYSTEM; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STOMACH EMPTYING; SUBCUTANEOUS FAT; SUPRAOPTIC NUCLEUS; TUMOR; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL MODEL; ENERGY METABOLISM; HISTOLOGY; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; SENSORY NERVE;

ADIPOSE TISSUE; AFFERENT PATHWAYS; ANIMALS; CYTOKINES; ENERGY METABOLISM; HUMANS; HYPOTHALAMUS; MODELS, BIOLOGICAL; PEPTIDE HORMONES;

EID: 33746722145     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(06)53022-5     Document Type: Review

References (245)

1. Aguilera A., Selgas R., Codoceo R., and Bajo A. Uremic anorexia: a consequence of persistently high brain serotonin levels? The tryptophan/serotonin disorder hypothesis. Perit. Dial. Int. 20 (2000) 810-816
2. Argiles J.M., Lopez-Soriano F.J., Evans R.D., and Williamson D.H. Interleukin-1 and lipid metabolism in the rat. Biochem. J. 259 (1989) 673-678
3. Arletti R., Benelli A., and Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides 10 (1989) 89-93
4. Arletti R., Benelli A., and Bertolini A. Oxytocin inhibits food and fluid intake in rats. Physiol. Behav. 48 (1990) 825-830
5. Armstrong M.D., and Klein J.R. Immune-endocrine interactions of the hypothalamus-pituitary-thyroid axis: integration, communication and homeostasis. Arch. Immunol. Ther. Exp. (Warsz), 49 (2001) 231-237
6. Arsenijevic D., and Richard D. A predominant role for INF-γ in infection induced cachexia in comparison to TNF-α (abstract). Appetite 33 (1999) 232
7. Banks W.A., Ortiz L., Plotkin S.R., and Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259 (1991) 988-996
8. Barber M.D., Ross J.A., Voss A.C., Tisdale M.J., and Fearon K.C. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br. J. Cancer 81 (1999) 80-86
9. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
10. Bartholomew S.A., and Hoffman S.A. Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav. Immun. 7 (1993) 301-316
11. Bartoli G.M., Palozza P., Marra G., Armelao F., Franceschelli P., Luberto C., Sgarlata E., Piccioni E., and Anti M. ω-3 PUFA and alpha-tocopherol control of tumor cell proliferation. Mol. Aspects. Med. 14 (1993) 247-252
12. Baumann H., and Gauldie J. The acute phase response. Immunol. Today 15 (1994) 74-80
13. Bazan N.G., Packard M.G., Teather L., and Allan G. Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30 (1997) 225-231
14. Beatty W.W., O'Brien D.A., and Vilberg T.R. Suppression of feeding by intrahypothalamic implants of estradiol in male and female rats. Bull. Psychonom. Soc. 3 (1974) 273-274
15. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
16. Bette M., Schafer M.K., van Rooijen N., Weihe E., and Fleischer B. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J. Exp. Med. 178 (1993) 1531-1539
17. Beutler B.A., and Cerami A. Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J. Immunol. 135 (1985) 3969-3971
18. Bird T.A., Davies A., Baldwin S.A., and Saklatvala J. Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J. Biol. Chem. 265 (1990) 13578-13583
19. Blaha V., Yang Z.-J., Meguid M.M., Laviano A., Zadack Z., and Rossi-Fanelli F. Cancer anorexia is modulated by interaction of hypothalamic-VMN dopamine (DA) and serotonin (5-HT) and not solely 5-HT as currently thought. Surg. Forum. 47 (1996) 517-520
20. Blatteis C.M. Role of the OVLT in the febrile response to circulating pyrogens. Prog. Brain Res. 91 (1992) 409-412
21. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
22. Bouman A., Schipper M., Heineman M.J., and Faas M.M. Gender difference in the non-specific and specific immune response in humans. Am. J. Reprod. Immunol. 52 (2004) 19-26
23. Broberger C., De Lecea L., Sutcliffe J.G., and Hokfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J. Comp. Neurol. 402 (1998) 460-474
24. Broberger C., Johansen J., Brismar H., Johansson C., Schalling M., and Hokfelt T. Changes in neuropeptide Y receptors and pro-opiomelanocortin in the anorexia (anx/anx) mouse hypothalamus. J. Neurosci. 19 (1999) 7130-7139
25. Broberger C., Johansen J., Schalling M., and Hokfelt T. Hypothalamic neurohistochemistry of the murine anorexia (anx/anx) mutation: altered processing of neuropeptide Y in the arcuate nucleus. J. Comp. Neurol. 387 (1997) 124-135
26. Butera P.C., and Beikirch R.J. Central implants of diluted estradiol: independent effects on ingestive and reproductive behaviors of ovariectomized rats. Brain Res. 491 (1989) 266-273
27. Campbel R.E., French-Mullen J.M., Cowley M.A., Smith M.S., and Grove K.L. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology 74 (2001) 106-119
28. Campos A.C., Oler A., Meguid M.M., and Chen T.Y. Liver biochemical and histological changes with graded amounts of total parenteral nutrition. Arch. Surg. 125 (1990) 447-450
29. Cangiano C., Testa U., Muscaritoli M., Meguid M.M., Mulieri M., Laviano A., Cascino A., Preziosa I., Conversano L., and Rossi-Fanelli F. Cytokines, tryptophan and anorexia in cancer patients before and after surgical tumor ablation. Anticancer Res. 14 (1994) 1451-1455
30. Card J.P., and Moore R.Y. Neuropeptide Y localization in the rat suprachiasmatic nucleus and periventricular hypothalamus. Neurosci. Lett. 88 (1988) 241-246
31. Ceppi E.D., Knowles R.G., Carpenter K.M., and Titheradge M.A. Effect of treatment in vivo of rats with bacterial endotoxin on fructose 2,6-bisphosphate metabolism and L-pyruvate kinase activity and flux in isolated liver cells. Biochem. J. 284 (1992) 761-766
32. Chai J.-K., Blaha V., Meguid M.M., Yang Z.-J., Varma M., and Laviano A. Use of orchiectomy and testosterone replacement to explore meal number to meal size relationship in male rats. Am. J. Physiol. 45 (1999) R1366-R1373
33. Chance W.T., Balasubramaniam A., Dayal R., Brown J., and Fischer J.E. Hypothalamic concentration and release of neuropeptideY into microdialysates is reduced in anorectic tumor-bearing rats. Life Sci. 54 (1994) 1869-1874
34. Chance W.T., Balasubramaniam A., Sheriff S., and Fischer J.E. Possible role of neuropeptide Y in experimental cancer anorexia. Adv. Exp. Med. Biol. 354 (1994) 185-201
35. Chance W.T., and Fischer J.E. Aphagic and adipsic effects of interleukin-1. Brain Res. 568 (1991) 261-264
36. Chance W.T., Sheriff S., Dayal R., and Balasubramaniam A. Refractory hypothalamic alpha-MSH satiety and AGRP feeding systems in rats bearing MCA sarcomas. Peptides 24 (2003) 1909-1919
37. Chance W.T., Sheriff S., Kasckow J.W., Regmi A., and Balasubramaniam A. NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats. Regul. Pept. 75-76 (1998) 347-353
38. Chen Z.Y., and Istfan N.W. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 301-308
39. Christ B., and Nath A. Impairment by interleukin 1 beta and tumour necrosis factor alpha of the glucagon-induced increase in phosphoenolpyruvate carboxykinase gene expression and gluconeogenesis in cultured rat hepatocytes. Biochem. J. 320 (1996) 161-166 Erratum in: Biochem. J., 1997 321: 903
40. Coe J.E., and Ross M.J. Hamster female protein. A divergent acute phase protein in male and female Syrian hamsters. J. Exp. Med. 157 (1983) 1421-1433
41. Conn C.A., McClellan J.L., Maassab H.F., Smitka C.W., Majde J.A., and Kluger M.J. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268 (1995) R78-R84
42. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., and Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24 (1999) 155-163
43. Cravo M.L., Gloria L.M., and Claro I. Metabolic responses to tumor disease and progression: tumor-host interaction. Clin. Nutr. 19 (2000) 459-465
44. Cunningham Jr. E.T., and De Souza E.B. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today 14 (1993) 171-176
45. Currie P.J., Coiro C.D., Niyomchai T., Lira A., and Farahnmmand F. Hypothalamic paraventricular 5-hydroxytryptamine: receptor specific inhibition of NPY-stimulated eating and energy metabolism. Pharmacol. Biochem. Behav. 71 (2002) 709-716
46. Currie P.J., and Coscina D.V. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. NeuroReport 8 (1997) 3759-3762
47. Dagnault A., and Richard D. Involvement of the medial preoptic area in the anorectic action of estrogens. Am. J. Physiol. 272 (1997) R311-R317
48. Dagnelie P.C., Bell J.D., Williams S.C., Bates T.E., Abel P.D., and Foster C.S. Effect of fish oil on cancer cachexia and host liver metabolism in rats with prostate tumors. Lipids 29 (1994) 195-203
49. Das U.N., Ramos E.J., and Meguid M.M. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 413-419
50. Debonis D., Meguid M.M., Laviano A., Yang Z.J., and Gleason J.R. Temporal changes in meal number and meal size relationship in response to rHu IL-1α. NeuroReport 6 (1995) 1752-1756
51. Deitch E.A., Xu D., Franko L., Ayala A., and Chaudry I.H. Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1 (1994) 141-144
52. De Laurentiis A., Pisera D., Caruso C., Candolfi M., Mohn C., Rettori V., and Seilicovich A. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis. Neuroimmunomodulation 10 (2002) 30-39
53. Del Rey A., and Besedovsky H. Interleukin 1 affects glucose homeostasis. Am. J. Physiol. 253 (1987) R794-R798
54. Del Rey A., and Besedovsky H. Antidiabetic effects of interleukin 1. Proc. Natl. Acad. Sci. USA 86 (1989) 5943-5947
55. Del Rey A., and Besedovsky H.O. Metabolic and neuroendocrine effects of pro-inflammatory cytokines. Eur. J. Clin. Invest. 22 (1992) 10-15
56. Del Rey A., Kabiersch A., Petzoldt S., and Besedovsky H.O. Involvement of noradrenergic nerves in the activation and clonal deletion of T cells stimulated by superantigen in vivo. J. Neuroimmunol. 127 (2002) 44-53
57. Del Rey A., Monge-Arditi G., and Besedovsky H.O. Central and peripheral mechanisms contribute to the hypoglycemia induced by interleukin-1. Ann. NY. Acad. Sci. 840 (1998) 153-161
58. Delrue C., Deleplanque B., Rouge-Pont F., Vitiello S., and Neveu P.J. Brain monoaminergic, neuroendocrine, and immune responses to an immune challenge in relation to brain and behavioral lateralization. Brain Behav Immun. 8 (1994) 137-152
59. Doerrler W., Feingold K.R., and Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6 (1994) 478-484
60. Dryden S., Frankish H.M., Wang Q., and Williams G. Neuropeptide Y and energy balance: one-way ahead from the treatment of obesity. J. Clin. Invest. 24 (1994) 293-308
61. Dryden S., Wang Q., Frankish H.M., Pickavance L., and Williams G. The serotonin (5-HT) antagonist metysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat. Brain Res. 699 (1995) 12-18
62. Dubuis J.M., Dayer J.M., Siegrist-Kaiser C.A., and Burger A.G. Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 123 (1988) 2175-2181
63. Dunn A.J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1. J. Pharmacol. Exp. Ther. 261 (1992) 964-969
64. Eckel L.A., and Geary N. Estradiol treatment increases feeding induced c-Fos expression in the brains of ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R738-R746
65. Eckel L.A., Houpt T.A., and Geary N. Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R1378-R1385
66. Ek M., Kurosawa M., Lundeberg T., and Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 18 (1998) 9471-9479
67. El-Haj T., Poole S., Farthing M.J., and Ballinger A.B. Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin. Brain Res. 927 (2002) 1-7
68. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., Flier J.S., Saper C.B., and Elmquist J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23 (1999) 775-786
69. Elias C.F., Lee C., Kelly J., Aschkenasi C., Ahima R.S., Couceyro P.R., Kuhar M.J., Saper C.B., and Elmquist J.K. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21 (1998) 1375-1385
70. Elmquist J.K., and Marcus J.N. Rethinking the central causes of diabetes. Nat. Med. 9 (2003) 645-647
71. Elmquist J.K., and Saper C.B. Activation of neurons projecting to the paraventricular hypothalamic nucleus by intravenous lipopolysaccharide. J. Comp. Neurol. 374 (1996) 315-331
72. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.W., Cannon J.G., Rogers T.S., Klempner M.S., and Weber P.C. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320 (1989) 265-271
73. Ericsson A., Arias C., and Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 17 (1997) 7166-7179
74. Ericsson A., Liu C., Hart R.P., and Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361 (1995) 681-698
75. Espat N.J., Auffenberg T., Rosenberg J.J., Rogy M., Martin D., Fang C.H., Hasselgren P.O., Copeland E.M., and Moldawer L.L. Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response. Am. J. Physiol. 271 (1996) R185-R190
76. Fantino M., and Wieteska L. Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat. Physiol. Behav. 53 (1993) 477-483
77. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919
78. Feingold K.R., Soued M., Adi S., Staprans I., Neese R., Shigenaga J., Doerrler W., Moser A., Dinarello C.A., and Grunfeld C. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor. Arterioscler. Thromb. 11 (1991) 495-500
79. Feingold K.R., Staprans I., Memon R.A., Moser A.H., Shigenaga J.K., Doerrler W., Dinarello C.A., and Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid. Res. 33 (1992) 1765-1776
80. Feldman S., Conforti N., and Melamed E. Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res. Bull. 18 (1987) 165-168
81. Fernstrom J.D., and Wurtman R.J. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178 (1972) 414-416
82. Fischereder M., Schroppel B., Wiese P., Fink M., Banas B., Schmidbauer S., and Schlondorff D. Regulation of glucose transporters in human peritoneal mesothelial cells. J. Nephrol. 16 (2003) 103-109
83. Flanagan-Cato L.M., King J.F., Blechman J.G., and O'Brien M.P. Estrogen reduces cholecystokinin-induced c-Fos expression in the rat brain. Neuroendocrinology 67 (1998) 384-391
84. Garcia-Welsh A., Schneiderman J.S., and Baly D.L. Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1 beta and IL-1 alpha. FEBS Lett. 269 (1990) 421-424
85. Gelin J., Moldawer L.L., Lonnroth C., Sherry B., Chizzonite R., and Lundholm K. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res. 51 (1991) 415-421
86. Gloaguen I., Costa P., Demartis A., Lazzaro D., Di Marco A., Graziani R., Paonessa G., Chen F., Rosenblum C.I., Van der Ploeg L.H., Cortese R., Ciliberto G., and Laufer R. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc. Natl. Acad. Sci. USA 94 (1997) 6456-6461
87. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., and Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 85 (2000) 49-59
88. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., and Watkins L.R. Interleukin-1β in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 19 (1999) 2799-2806
89. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., and Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 43 (1997) 357-364
90. Gonzalez M.C., Abreu P., Barroso-Chinea P., Cruz-Muros I., and Gonzalez-Hernandez T. Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat. Neuroscience 127 (2004) 251-259
91. Gregoire F., De Broux N., Hauser N., Heremans H., Van Damme J., and Remacle C. Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J. Cell. Physiol. 151 (1992) 300-309
92. Hansen K., Sickelmann F., Pietrowsky R., Fehm H.L., and Born J. Systemic immune changes following meal intake in humans. Am. J. Physiol. 273 (1997) R548-R553
93. Hansen M.K., Taishi P., Chen Z., and Krueger J.M. Cafeteria feeding induces interleukin-1beta mRNA expression in rat liver and brain. Am. J. Physiol. 274 (1998) R1734-R1739
94. Hansen S., Sodersten P., Eneroth P., Srebro B., and Hole K. A sexually dimorphic rhythm in oestradiol-activated lordosis behaviour in the rat. J. Endocrinol. 82 (1979) 267-274
95. Hansen S., Sodersten P., and Srebo B. A daily rhythm in the behavioral sensitivity of the female rat to oestradiol. J. Endocrinol. 77 (1978) 381-388
96. Hardardottir I., Grunfeld C., and Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5 (1994) 207-215
97. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 12 (1988) 123-137
98. Hart B.L. Behavioral adaptations to pathogens and parasites: five strategies. Neurosci. Biobehav. Rev. 14 (1990) 273-294
99. Herkenham M., Lee H.Y., and Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 400 (1998) 175-196
100. Hermus R.M., Sweep C.G., van der Meer M.J., Ross H.A., Smals A.G., Benraad T.J., and Kloppenborg P.W. Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat. Endocrinology 131 (1992) 2139-2146
101. Hirai C.Y., and Limaos E.A. Effect of sex steroids on the circulating levels of alpha 2-macroglobulin in injured rats. Braz. J. Med. Biol. Res. 23 (1990) 1021-1024
102. Hosoi T., Okuma Y., and Nomura Y. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R141-R147
103. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
104. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key?. Cancer Res. 59 (1999) 4493-4501
105. Itoh T., Iwai H., and Ueda K. Comparative lung pathology of inbred strain of mice resistant and susceptible to Sendai virus infection. J. Vet. Med. Sci. 53 (1991) 275-279
106. Jho D.H., Babcock T.A., Tevar R., Helton W.S., and Espat N.J. Eicosapentaenoic acid supplementation reduces tumor volume and attenuates cachexia in a rat model of progressive non-metastasizing malignancy. JPEN J. Parenter. Enteral Nutr. 26 (2002) 291-297
107. Kanemaki T., Kitade H., Kaibori M., Sakitani K., Hiramatsu Y., Kamiyama Y., Ito S., and Okumura T. Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology I 27 (1998) 1296-1303
108. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., and Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid. Res. 45 (2004) 1169-1196
109. Kitano T., Okumura T., Nishizawa M., Liew F.Y., Seki T., Inoue K., and Ito S. Altered response to inflammatory cytokines in hepatic energy metabolism in inducible nitric oxide synthase knockout mice. J. Hepatol. 36 (2002) 759-765
110. Klasing K.C. Nutritional aspects of leukocytic cytokines. J. Nutr. 118 (1988) 1436-1446
111. Konsman J.P., Luheshi G.N., Bluthe R.M., and Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur. J. Neurosci. 12 (2000) 4434-4446
112. Kozak W., Zheng H., Conn C.A., Soszynski D., van der Ploeg L.H., and Kluger M.J. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am. J. Physiol. 269 (1995) R969-R977
113. Kremer J.M., and Robinson D.R. Studies of dietary supplementation with omega 3 fatty acids in patients with rheumatoid arthritis. World Rev. Nutr. Diet. 66 (1991) 367-382
114. Kunkel S.L., and Chensue S.W. Arachidonic acid metabolites regulate interleukin-1 production. Biochem. Biophys. Res. Commun. 128 (1985) 892-897
115. Kuriyama K., Hori T., Mori T., and Nakashima T. Actions of interferon alpha and interleukin- 1 beta on the glucose-responsive neurons in the ventromedial hypothalamus. Brain. Res. Bull. 24 (1990) 803-810
116. Kurzer M.J., Janiszewsky J., and Meguid M.M. Aminoacid profiles in tumor bearing and non-tumor bearing malnourished rats. Cancer 62 (1988) 1492-1496
117. Kusnecov A.W., Liang R., and Shurin G. T-lymphocyte activation increases hypothalamic and amygdaloid expression of CRH mRNA and emotional reactivity to novelty. J. Neurosci. 19 (1999) 4533-4543
118. Lambert P.D., Anderson K.D., Sleeman M.W., Wong V., Tan J., Hijarunguru A., Corcoran T.L., Murray J.D., Thabet K.E., Yancopoulos G.D., and Wiegand S.J. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc. Natl. Acad. Sci. USA 98 (2001) 4652-4657
119. Landel A.M., Lo C.C., and Meguid M.M. Observations on predicted brain influx rates of neurotransmitter precursors. Effects of tumor, operative stress with tumor removal, and postoperative TPN of varying amino acid compositions. Cancer 59 (1987) 1192-1200
120. Langhans W., Balkowski G., and Savoldelli D. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide. Am. J. Physiol. 261 (1991) R659-R664
121. Langhans W., Delprete E., and Scharrer E. Mechanisms of vasopressin's anorectic effect. Physiol. Behav. 49 (1991) 169-176
122. Lanza-Jacoby S., and Tabares A. Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats. Am. J. Physiol. 258 (1990) E678-E685
123. Laviano A., Cangiano C., Fava A., Muscaritoli M., Mulieri G., and Rossi-Fanelli F. Peripherally injected IL-1 induces anorexia and increases brain tryptophan concentrations. Adv. Exp. Med. Biol. 467 (1999) 105-108
124. Laviano A., Cangiano C., Preziosa I., Riggio O., Conversano L., Cascino A., Ariemma S., and Rossi-Fanelli F. Plasma tryptophan levels and anorexia in liver cirrhosis. Int. J. Eat. Disord. 21 (1997) 181-186
125. Laviano A., Gleason J.R., Meguid M.M., Yang Z.-J., Cangiano C., and Rossi-Fanelli F. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J. Investig. Med. 48 (2000) 40-48
126. Laviano A., Meguid M.M., Gleason J.R., Yang Z.-J., and Renvyle T. Comparison of long-term feeding pattern between male and female Fischer 344 rats: influence of estrous cycle. Am. J. Physiol. 270 (1996) R413-R419
127. Laviano A., Meguid M.M., and Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol. 4 (2003) 686-994
128. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2 (2002) 725-734
129. Maitra S.R., Wang S., Brathwaite C.E., and El-Maghrabi M.R. Alterations in glucose-6-phosphatase gene expression in sepsis. J. Trauma 49 (2000) 38-42
130. 1B receptors in the normal rat hypothalamus. Neurosci. Lett. 328 (2002) 155-159
131. 1B) receptor and NPY in cancer anorexia after tumor resection: an immunocytochemical study. Neurosci. Lett. 383 (2005) 322-327
132. 1B- receptor changes in the anorectic tumor bearing rats. Neurosci. Lett. 376 (2005) 71-75
133. Makarenko I.G., Meguid M.M., Gatto L., Chen C., and Ugrumov M.V. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res. 961 (2003) 100-108
134. Mascarucci P., Perego C., Terrazzino S., and De Simoni M.G. Glutamate release in the nucleus tractus solitarius induced by peripheral lipopolysaccharide and interleukin-1 beta. Neuroscience 86 (1998) 1285-1290
135. Matsuki T., Horai R., Sudo K., and Iwakura Y. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J. Exp. Med. 198 (2003) 877-888
136. Meguid M.M., Chen T.-Y., Yang Z.-J., Campos A.C., Hitch D.C., and Gleason J.R. Effects of continuous graded TPN on feeding indexes and metabolic concomitants in rats. Am. J. Physiol. 260 (1991) E126-E140
137. Meguid M.M., Fetissov S.O., Miyata G., and Torelli G.F. Feeding pattern in obese Zucker rats after dopaminergic and serotonergic LHA grafts. Neuroreport 10 (1999) 1049-1053
138. Meguid M.M., Kawashima Y., Campos A.C.L., Gelling P., Hill T.W., Chen T.-Y., Hitch D.C., Mueller W.J., and Hammond W.G. Automated computerized rat eater meter: description and application. Physiol. Behav. 48 (1990) 759-763
139. Meguid M.M., Landel A.M., Lo C.-C., and Rivera D. Effect of tumor and tumor removal on DNA, RNA, protein tissue content and survival of methylcholanthrene sarcoma-bearing rat. Surg. Res. Commun. 1 (1987) 261-271
140. Meguid M.M., Laviano A., and Rossi-Fanelli F. Food intake equals meal size times mean number. Appetite 31 (1998) 404
141. Meguid M.M., Muscaritoli M., Beverly J.L., Yang Z.J., Cangiano C., and Rossi-Fanelli F. The early cancer anorexia paradigm: changes in plasma-free tryptophan and feeding indexes. J. Parenter. Enteral. Nutr. 16 (1992) 56S-59S
142. Meguid M.M., and Pichard C. Cytokines: the mother of catabolic mediators. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 383-386
143. Meguid M.M., Ramos E.J.B., Laviano A., Varma M., Sato T., Cheng C., Qi Y., and Das U.N. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides 25 (2004) 261-266
144. Meguid M.M., Sato T., Torelli G.F., Laviano A., and Rossi-Fanelli F. An analysis of temporal changes in meal number and meal size at onset of anorexia in male tumor-bearing rats. Nutrition 16 (2000) 305-306
145. Meguid M.M., Yang Z.J., and Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res. Bull. 36 (1995) 487-490
146. Meguid M.M., Yang Z.J., and Laviano A. Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. Am. J. Physiol. 272 (1997) R1925-R1930
147. Meguid M.M., Yang Z.-J., and Montante A. Lateral hypothalamic dopaminergic neural activity in response to TPN. Surgery 114 (1993) 400-406
148. Memon R.A., Feingold K.R., Moser A.H., Fuller J., and Grunfeld C. Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am. J. Physiol. 274 (1998) E210-E217
149. Memon R.A., Fuller J., Moser A.H., Smith P.J., Feingold K.R., and Grunfeld C. In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. Am. J. Physiol. 275 (1998) E64-E72
150. Memon R.A., Grunfeld C., Moser A.H., and Feingold K.R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 132 (1993) 2246-2253
151. Meterissian S.H., Forse R.A., Steele G.D., and Thomas P. Effect of membrane free fatty acid alterations on the adhesion of human colorectal carcinoma cells to liver macrophages and extracellular matrix proteins. Cancer Lett. 89 (1995) 145-152
152. Metzger S., Begleibter N., Barash V., Drize O., Peretz T., Shiloni E., and Chajek-Shaul T. Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro. Metabolism 46 (1997) 579-583
153. Metzger S., Hassin T., Barash V., Pappo O., and Chajek-Shaul T. Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E957-E965
154. Metzger S., Nusair S., Planer D., Barash V., Pappo O., Shilyansky J., and Chajek-Shaul T. Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta-secreting tumor. Endocrinology 145 (2004) 5150-5156
155. Miyata G., Meguid M.M., Fetissov S.O., Torelli G.F., and Kim H.J. Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery 126 (1999) 255-263
156. MohanKumar S.M., MohanKumar P.S., and Quadri S.K. Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res. Bull. 47 (1998) 29-34
157. MohanKumar S.M., MohanKumar P.S., and Quadri S.K. Lipopolyssacharide-induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Res. 10 (1999) 232-237
158. Muscaritoli M., Meguid M.M., Beverly J.L., Yang Z.J., Cangiano C., and Rossi-Fanelli F. Mechanism of early tumor anorexia. J. Surg. Res. 60 (1996) 389-397
159. Nachiappan V., Curtiss D., Corkey B.E., and Kilpatrick L. Cytokines inhibit fatty acid oxidation in isolated rat hepatocytes: synergy among TNF, IL-6, and IL-1. Shock 1 (1994) 123-129
160. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J. Auton. Nerv. Syst. 61 (1996) 287-291
161. Niijima A., and Meguid M.M. Parenteral nutrients in rat suppress hepatic vagal afferent signals from portal vein to hypothalamus. Surgery 116 (1994) 294-301
162. Niijima A., and Meguid M.M. An electrophysiological study on amino acid sensors in the hepato-portal system in the rat. Obes. Res. 5 (1995) 741S-745S
163. Niijima A., and Meguid M.M. Influence of systemic arginine-lysine on immune organ function: an electrophysiology study. Brain Res. Bull. 45 (1998) 437-441
164. Noguchi Y., Yoshikawa T., Matsumoto A., Svaninger G., and Gelin J. Are cytokines possible mediators of cancer cachexia?. Surg. Today. 26 (1996) 467-475
165. Nolan Y., Connor T.J., Kelly J.P., and Leonard B.E. Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain. J. Neural. Transm. 107 (2000) 1393-1401
166. Olson B.R., Drutarowsky M.D., Chow M.S., Hruby V.J., Stricker E.M., and Verbalis J.G. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12 (1991) 113-118
167. Opara E.I., Laviano A., Meguid M.M., and Yang Z.-J. Correlation between food intake and CSF IL-l in anorectic tumor-bearing rats. NeuroReport 6 (1995) 750-752
168. Opara E.I., Meguid M.M., Yang Z.-J., Chai J.-K., and Veerabagu M. Tumor necrosis factor-α and TPN-induced anorexia. Surgery 18 (1995) 756-762
169. Opara E.I., Meguid M.M., Yang Z.J., and Hammond W.G. Studies on the regulation of food intake using rat total parenteral nutrition as a model. Neurosci. Biobehav. Rev. 20 (1996) 413-443
170. Ottaway C.A., and Husband A.J. The influence of neuroendocrine pathways on lymphocyte migration. Immunol. Today 15 (1994) 511-517
171. Pacheco-Lopez G., Niemi M.B., Kou W., Harting M., Del Rey A., Besedovsky H.O., and Schedlowski M. Behavioural endocrine immune-conditioned response is induced by taste and superantigen pairing. Neuroscience 129 (2004) 555-562
172. Pich E.M., Messori B., Zoli M., Ferraguti F., Marrama P., Biagini G., Fuxe K., and Agnati L.F. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats. Brain Res. 575 (1992) 265-271
173. Plata-Salaman C.R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15 (1991) 185-215
174. Plata-Salaman C.R. Cytokine action in the nervous system at pathophysiological versus pharmacological concentrations. Adv. Exp. Med. Biol. 402 (1996) 191-197
175. Plata-Salaman C.R. Anorexia during acute and chronic disease: relevance of neurotransmitter-peptide-cytokine interactions. Nutrition 13 (1997) 159-160
176. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 16 (2000) 1009-1012
177. Plata-Salaman C.R., and Borkoski J.P. Interleukin-8 modulates feeding by direct action in the central nervous system. Am. J. Physiol. 265 (1993) R877-R882
178. Plata-Salaman C.R., and Ffrench-Mullen J.M. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1 beta. Physiol. Behav. 51 (1992) 1277-1279
179. Plata-Salaman C.R., Oomura Y., and Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 448 (1998) 106-114
180. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., and French-Mullen J.M. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol. Behav. 60 (1996) 867-875
181. Plotsky P.M., Cunningham Jr. E.T., and Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev. 10 (1989) 437-458
182. Porter M.H., Arnold M., and Langhans W. Lipopolysaccharide-induced anorexia following hepatic portal vein and vena cava administration. Physiol. Behav. 64 (1998) 581-584
183. Porter M.H., Hrupka B.J., Altreuther G., Arnold M., and Langhans W. Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifylline. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 (2000) R2113-R2120
184. Posma E., Moes H., Heineman M.J., and Faas M.M. The effect of testosterone on cytokine production in the specific and non-specific immune response. Am. J. Reprod. Immunol. 52 (2004) 237-243
185. Pu S., Dhillon H., Moldawer L.L., Kalra P.S., and Kalra S.P. Neuropeptide Y counteracts the anorectic and weight reduction effects of ciliary neurotropic factor. J. Neuroendocrinol. 12 (2000) 827-832
186. Ramos E.J., Meguid M.M., Zhang L., Miyata G., Fetissov S.O., Chen C., Suzuki S., and Laviano A. Nicotine infusion into rat ventromedial nuclei and effects on monoaminergic system. Neuroreport 15 (2004) 2293-2297
187. Ramos E.J.B., Middelton F.A., Laviano A., Sato T., Romanova I., Das U., Cheng C., Qi Y., and Meguid M.M. Effects of omega -3 fatty acid supplementation on tumor-bearing rats. J. Am. Coll. Surg. 199 (2004) 716-723
188. Ramos E.J.B., Romanova I., Suzuki S., Cheng C., Ugrumov M.V., Sato T., Goncalves C.G., and Meguid M.M. Effects of omega -3 fatty acid on orexigenic and anorexigenic modulators at the onset of anorexia. Brain Res. 1046 (2005) 157-164
189. Ramos E.J.B., Suzuki S., Meguid M.M., Laviano A., Sato T., Cheng C., and Das U. Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: Pre- and post-tumor resection and death. Surgery 136 (2004) 270-276
190. Ramos E.J., Xu Y., Romanova I., Middleton F., Chen C., Quinn R., Inui A., Das U., and Meguid M.M. Is obesity an inflammatory disease?. Surgery 134 (2003) 329-335
191. Reyes T.M., and Sawchenko P.E. Involvement of the arcuate nucleus of the hypothalamus in interleukin-1-induced anorexia. J. Neurosci. 22 (2002) 5091-5099
192. Ricardo J.A., and Koh E.T. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res. 153 (1978) 1-26
193. Rogers P., McKibbin P.E., and Williams G. Acute fenfluramine administration reduces neuropeptide Y concentration in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine. Peptides 12 (1997) 251-255
194. Rola-Pleszczynski M., and Lemaire I. Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135 (1985) 3958-3961
195. Rose D.P., Connolly J.M., and Meschter C.L. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J. Natl. Cancer. Inst. 83 (1991) 1491-1495
196. Rosendahl A., Hansson J., Antonsson P., Sekaly R.P., Kalland T., and Dohlsten M. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo. Infect. Immun. 65 (1997) 5118-5124
197. Rossi-George A., Urbach D., Colas D., Goldfarb Y., and Kusnecov A.W. Neuronal, endocrine, and anorexic responses to the T-cell superantigen staphylococcal enterotoxin A: dependence on tumor necrosis factor-alpha. J. Neurosci. 25 (2005) 5314-5322
198. Rothwell N.J., Busbridge N.J., Lefeuvre R.A., Hardwick A.J., Gauldie J., and Hopkins S.J. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can. J. Physiol. Pharmacol. 69 (1991) 1465-1469
199. Saper C.B., Chou T.C., and Elmquist J.K. The need to feed: homeostatic and hedonic control of eating. Neuron 36 (2002) 199-211
200. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
201. Sasaki T., Kudoh K., Uda Y., Ozawa Y., Shimizu J., Kanke Y., and Takita T. Effects of isothiocyanates on growth and metastaticity of B16-F10 melanoma cells. Nutr. Cancer 33 (1999) 76-81
202. Sato T., Fetissov S.O., Meguid M.M., Miyata G., and Chen C. Intra-supraoptic nucleus sulpiride improves anorexia in tumor-bearing rats. Neuroreport 12 (2001) 2429-2432
203. Sato T., Laviano A., Meguid M.M., Chen C., Rossi-Fanelli F., and Hatakeyama K. Involvement of plasma leptin, insulin and free tryptophan in cytokine-induced anorexia. Clin. Nutr. 22 (2003) 139-146
204. Sato T., Meguid M.M., Fetissov S.O., Chen C., and Zhang L. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R1907-R1916
205. Sato T., Meguid M.M., Quinn R.H., Zhang L., and Chen C. Feeding behavior during sialodacryoadenitis viral infection in rats. Physiol. Behav. 72 (2001) 721-726
206. Sawchenko P.E., and Swanson L.W. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 6 (1983) 269-324
207. Sawchenko P.E., Swanson L.W., Steinbusch H.W., and Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277 (1983) 355-360
208. Schaechter J.D., and Wurtman R.J. Serotonin release varies with brain tryptophan levels. Brain Res. 532 (1990) 203-210
209. Shikhman A.R., Brinson D.C., Valbracht J., and Lotz M.K. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J. Immunol. 167 (2001) 7001-7008
210. Shurin G., Shanks N., Nelson L., Hoffman G., Huang L., and Kusnecov A.W. Hypothalamic-pituitary-adrenal activation by the bacterial superantigen staphylococcal enterotoxin B: role of macrophages and T cells. Neuroendocrinology 65 (1997) 18-28
211. Smagin G.N., Swiergiel A.H., and Dunn A.J. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21 (1996) 83-93
212. Smith B.K., and Kluger M.J. Anti-TNF-alpha antibodies normalized body temperature and enhanced food intake in tumor-bearing rats. Am. J. Physiol. 265 (1993) R615-R619
213. Smith J.W., Urba W.J., Steis R.G., Janik J.E., Fenton R.G., Sharfman W.H., Conlon K.C., Sznol M., Creekmore S.P., Wells N., Elwood L., Keller J., Hestdal K., Ewel C., Rossio J., Kopp W.C., Shimuzi M., Oppenheim J.J., and Longo D.L. Phase I trial of interleukin 1 alpha (IL-1 alpha) alone and in combination with indomethacin. Lymphokine Res. 9 (1990) 568
214. Sonti G., Ilyin S.E., and Plata-Salaman C.R. Neuropeptide Y blocks and reverses interleukin-1β-induced anorexia in rats. Peptides 17 (1996) 517-520
215. Spitzer J.A., and Zhang P. Protein tyrosine kinase activity and the influence of gender in phagocytosis and tumor necrosis factor secretion in alveolar macrophages and lung-recruited neutrophils. Shock 6 (1996) 426-433
216. Spitzer J.A., and Zhang P. Gender differences in neutrophil function and cytokine-induced neutrophil chemoattractant generation in endotoxic rats. Inflammation 20 (1996) 485-498
217. Stadler J., Barton D., Beil-Moeller H., Diekmann S., Hierholzer C., Erhard W., and Heidecke C.D. Hepatocyte nitric oxide biosynthesis inhibits glucose output and competes with urea synthesis for L-arginine. Am. J. Physiol. 268 (1995) G183-G188
218. Stenlof K., Wernstedt I., Fjallman T., Wallenius V., Wallenius K., and Jansson J.O. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4379-4383
219. Sternson S.M., Shepherd G.M., and Friedman J.M. Topographic mapping of VMH → arcuate nucleus microcircuits and their reorganization by fasting. Nat. Neurosci. 8 (2005) 1356-1363
220. Sweep C.G., van der Meer M.J., Ross H.A., Vranckx R., Visser T.J., and Hermus A.R. Chronic infusion of TNF-alpha reduces plasma T4 binding without affecting pituitary-thyroid activity in rats. Am. J. Physiol. 263 (1992) E1099-E1105
221. Takeyama N., Itoh Y., Kitazawa Y., and Tanaka T. Altered hepatic mitochondrial fatty acid oxidation and ketogenesis in endotoxic rats. Am. J. Physiol. 259 (1990) E498-E505
222. Tocci M.J., and Schmidt J.A. Interleukin-1: structure and function. In: Remick D.G., and Friedland J.S. (Eds). Cytokines in Health and Disease. second edition (1997), Marcel Dekker, Inc., New York 1-27
223. Torelli G.F., Meguid M.M., Miyata G., Fetissov S.O., Carter J.L., Kim H.J., Muscaritoli M., and Rossi-Fanelli F. VMN hypothalamic dopamine and serotonin in anorectic septic rats. Shock 13 (2000) 204-208
224. Torelli G.F., Meguid M.M., Moldawer L.L., Edwards 3rd C.K., Kim H.J., Carter J.L., Laviano A., and Rossi-Fanelli F. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am. J. Physiol. 277 (1999) R850-R855
225. Turrin N.P., Ilyin S.E., Gayle D.A., Plata-Salaman C.R., Ramos E.J., Laviano A., Das U.N., Inui A., and Meguid M.M. Interleukin, system activation in anorectic catabolic tumor-bearing rats. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 419-426
226. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug. Discov. 4 (2005) 673-684
227. Varma M., Chai J.-K., Meguid M.M., Laviano A., Gleason J.R., Yang Z.-J., and Blaha V. Effect of estradiol and progesterone on daily rhythm in food intake and feeding patterns in Fischer rats. Physiol. Behav. 68 (1999) 99-107
228. Veerabagu M.P., Opara E.I., Meguid M.M., Nandi J., Oler A., Holtzapple P.G., and Levine R.A. Mode of food intake reduction in Lewis rats with indomethacin-induced ulcerative ileitis. Physiol. Behav. 60 (1996) 381-387
229. 2C receptor in central lipopolysaccharide-, interleukin-1β-, and leptin-induced anorexia. Pharmacol. Biochem. Behav. 74 (2003) 1025-1031
230. Wallenius K., Wallenius V., Sunter D., Dickson S.L., and Jansson J.O. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem. Biophys. Res. Commun. 293 (2002) 560-565
231. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., and Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8 (2002) 75-79
232. Wang J., Griggs N.D., Tung K.S., and Klein J.R. Dynamic regulation of gastric autoimmunity by thyroid hormone. Int. Immunol. 10 (1998) 231-236
233. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Wang H., Metz C., Miller E.J., Tracey K.J., and Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10 (2004) 1216-1221
234. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Wang H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
235. Watanobe H., and Yoneda M. A mechanism underlying the sexually dimorphic ACTH response to lipopolysaccharide in rats: sex steroid modulation of cytokine-binding sites in the hypothalamus. J. Physiol. 547 (2003) 221-232
236. Weinberg E.D. Iron withholding: a defense against infection and neoplasia. Physiol. Rev. 64 (1984) 65-102
237. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112 (2003) 1785-1788
238. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
239. Yabuuchi K., Minami M., Katsumata S., and Satoh M. Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res. Mol. Brain Res. 27 (1994) 27-36
240. Yang Z.J., Blaha V., meguid m.m., Laviano A., Oler A., and Zadak Z. Interleukin-1α injection into ventromedial hypothalamic nucleus of normal rats depress food intake and increases release of dopamine and serotonin. Pharmacol. Biochem. Behav. 1 (1999) 61-65
241. Yang Z.J., Koseki M., Meguid M.M., Gleason J.R., and Debonis D. Synergistic effect of rhTNF-alpha and rhIL-1 alpha in inducing anorexia in rats. Am. J. Physiol. 267 (1994) R1056-R1064
242. Yang Z.J., and Meguid M.M. Continuous systemic interleukin-1 alpha infusion suppresses food intake without increasing lateral hypothalamic dopamine activity. Brain Res. Bull. 36 (1995) 417-420
243. Yang Z.-J., Ratto C., Gleason J.R., Bellantone R., Crucitti F., and Meguid M.M. Influence of anterior subdiaphragmatic vagotomy and TPN on rat feeding behavior. Physiol. Behav. 51 (1992) 919-926
244. Yerkovich S.T., Rigby P.J., Fournier P.A., Olynyk J.K., and Yeoh G.C. Kupffer cell cytokines interleukin-1beta and interleukin-10 combine to inhibit phosphoenolpyruvate carboxykinase and gluconeogenesis in cultured hepatocytes. Int. J. Biochem. Cell. Biol. 36 (2004) 1462-1472
245. Zigman J.M., and Elmquist J.K. Minireview: from anorexia to obesity - the yin and yang of body weight control. Endocrinology 144 (2003) 3749-3756